Research and Insights

Capital ideas from the industry’s brightest minds.

In Equity Research, our award-winning analysts deliver superior investment ideas and value-added perspective for over 600 quality growth companies.

Under Insights, you will find firm publications, market commentaries, and white papers from our investment banking and asset management professionals.

Allogeneic cell therapies (derived from a healthy donor) provide an enhanced speed to patient, availability, decreased cell variability, and streamlined manufacturing efficiencies.


600+ companies under
          research coverage

60+ initiations in 2018